Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $23.00 (UBS)
- Lowest: $13.00 (Piper Sandler)
- Average: $17.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.40 (-2.5%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
Avg. $ Target:
$17.40 (-2.5%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2026 | UBS » Updated 7/15/2026 |
Ashwani Verma | New Coverage | Buy (N/A) |
23.00 (19.00) |
13.05 (17.85) |
36.78% | Details |
| 12/9/2025 | Barclays » Updated 5/20/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
16.00 (15.00) |
12.18 (17.85) |
46.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
